Lipocine Inc. 8-K

What Happened

• Lipocine, Inc. (LPCN) announced an “Other Events” disclosure by filing a Form 8-K on April 2, 2026. The filing attaches a corporate presentation as Exhibit 99.1. The cover page interactive data file (Inline XBRL) is also included as Exhibit 104.

Key Details

• Filing date: April 2, 2026 (Accession No. 0001493152-26-014835).
• Item reported: 8.01 — Other Events; Exhibit 99.1 = Corporate Presentation.
• Item 9.01 exhibits listed: 99.1 (presentation) and 104 (Cover Page Interactive Data File).
• The filing does not report earnings, revenue, executive changes, mergers, or other financial results.

Why It Matters

• The corporate presentation may provide updates on Lipocine’s strategy, pipeline, or corporate outlook; investors should review Exhibit 99.1 directly for details.
• Because this 8-K only furnishes a presentation (and no financial results or personnel changes), it is a disclosure update rather than a report of earnings or major corporate actions.